Skip to main content

Table 3 Change in FEV1 over 36 months stratified by baseline GOLD grades

From: Health-related quality of life associates with change in FEV1 in COPD: results from the COSYCONET cohort

 

Change in FEV1

 

decrease ≥ 100 ml

no change

increase ≥ 100 ml

GOLD 1/2 (n = 695)

63,6%

24,6%

11,8%

GOLD 3/4 (n = 478)

50,4%

33,7%

15,9%

Total sample (n = 1173)

58,2%

28,3%

13,5%

 Mean FEV1 change

− 311 ml

−11 ml

269 ml

 Responder1 SGRQ

29,1%

35,5%

48,4%

 Responder1 VAS

26,5%

37,2%

43,9%

  1. 1Indicates the percentage of patients who experienced a clinically relevant improvement in HRQL